STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #46 by analyst upside · 2026-06-24
IVF
INVO Fertility, Inc.
Healthcare · Market Cap $2M · P/E 0.0x
ANALYST PRICE TARGET
+1359.9%
implied upside to consensus target
Current Price $1.37
Consensus Target $20.0
Bull Target $20.0
Bear Target $20.0
Analysts Covering 1
ANALYST CONSENSUS — HOLD
Strong Buy
0
Buy
0
Hold
1
Sell
0
52-Week Low $1.26
52-Week High $183.6
YTD Return -69.6%
FUNDAMENTALS
Market Cap $2M
P/E Ratio (TTM) N/A
Forward P/E -0.2x
EPS (TTM) $250.64
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $7M
Profit Margin -158.7%
52-WEEK RANGE
52-Week Low $1.26
52-Week High $183.6
Current Price $1.37
Bear Target $20.0
Bull Target $20.0
● Now $1.37 ● Target $20.0
TRADING DATA
Avg Volume 299K
YTD Return -69.6%
Analyst Count 1
Consensus Hold
Upside to Target +1359.9%
Last Updated 2026-06-24

ANALYST SUMMARY

INVO Fertility, Inc. (IVF) is currently trading at $1.37 with a Wall Street consensus price target of $20.0, implying potential upside of 1359.9% over the next 12 months. 1 analysts currently cover IVF, with a consensus rating of Hold — 0% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $20.0, while the most cautious has a target of $20.0.

IVF operates in the Healthcare sector with a market capitalisation of $2M. The stock is down 69.6% year-to-date and is currently trading near the lower end of its 52-week range of $1.26 – $183.6.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →